AUG 11, 2026 · PHASE 3 TRIAL
A Study to Test the Effect of Survodutide (BI 456906) on Cardiovascular Safety in People With Overweight or Obesity (SYNCHRONIZE™ - CVOT)
ClinicalTrials.gov
Phase 3 cardiovascular outcomes trial with completed enrollment but no results posted in this registry record; the study design is rigorous but evidence cannot be assessed without outcome data.
Reported
Planned enrollment5531
Study phasePhase 3
Primary endpointTime to first occurrence of any adjudicated…